Travis S. Henry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Travis S. Henry has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Brian M. Haas
Department of Radiology and Biomedical Imaging, University of California, San Francisco (UCSF), CA
3 shared publications - Scott A. Hamlin
Emory University School of Medicine
3 shared publications - Annette T. Hastie
Department of Internal Medicine, School of Medicine, Wake Forest University, Winston-Salem, North Carolina
1 shared publication Bradley Kasper
Edward Via College of Osteopathic Medicine - Virginia Campus, Department of Medical Education, United States of America
1 shared publication- Brendan K. Huang
Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, and
1 shared publication - Brent P. Little
Mayo Clinic Florida and Mayo Clinic College of Medicine and Science, Jacksonville, FL
1 shared publication
Latest Publications
- 27 July 2025
- Published by Springer Nature
- p. 247-268
Imaging of Thoracic Vascular Trauma
- 11 May 2025
- Published by Elsevier in Clinical Imaging
- Vol. 123, 110505
Academic influence of American College of Radiology Appropriateness Criteria: a citation analysis of thoracic and cardiac imaging guidelines
- 11 May 2025
- Published by Elsevier in Clinical Imaging
- Vol. 123, 110505
Academic influence of American College of Radiology Appropriateness Criteria: a citation analysis of thoracic and cardiac imaging guidelines
- 10 January 2025
- Published by Springer Nature
- p. 1-22
Imaging of Thoracic Vascular Trauma
- Open Access
- 8 February 2024
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 9 (3)
Persistent mucus plugs in proximal airways are consequential for airflow limitation in asthma
BACKGROUND: Information about the size, airway location, and longitudinal behavior of mucus plugs in asthma is needed to understand their role in mechanisms of airflow obstruction and to rationally design muco-active treatments. METHODS: CT lung scans from 57 patients with asthma were analyzed to quantify mucus plug size and airway location, and paired CT scans obtained 3 years apart were analyzed to determine plug behavior over time. Radiologist annotations of mucus plugs were incorporated in an image-processing pipeline to generate size and location information that was related to measures of airflow. RESULTS: The length distribution of 778 annotated mucus plugs was multimodal, and a 12 mm length defined short (“stubby”, ≤12 mm) and long (“stringy”, >12 mm) plug phenotypes. High mucus plug burden was disproportionately attributable to stringy mucus plugs. Mucus plugs localized predominantly to airway generations 6–9, and 47% of plugs in baseline scans persisted in the same airway for 3 years and fluctuated in length and volume. Mucus plugs in larger proximal generations had greater effects on spirometry measures than plugs in smaller distal generations, and a model of airflow that estimates the increased airway resistance attributable to plugs predicted a greater effect for proximal generations and more numerous mucus plugs. CONCLUSION: Persistent mucus plugs in proximal airway generations occur in asthma and demonstrate a stochastic process of formation and resolution over time. Proximal airway mucus plugs are consequential for airflow and are in locations amenable to treatment by inhaled muco-active drugs or bronchoscopy. TRIAL REGISTRATION: Clinicaltrials.gov; NCT01718197, NCT01606826, NCT01750411, NCT01761058, NCT01761630, NCT01716494, and NCT01760915. FUNDING: AstraZeneca, Boehringer-Ingelheim, Genentech, GlaxoSmithKline, Sanofi–Genzyme–Regeneron, and TEVA provided financial support for study activities at the Coordinating and Clinical Centers beyond the third year of patient follow-up. These companies had no role in study design or data analysis, and the only restriction on the funds was that they be used to support the SARP initiative.
- 8 February 2024
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 9 (3)
Open AccessPersistent mucus plugs in proximal airways are consequential for airflow limitation in asthma
BACKGROUND: Information about the size, airway location, and longitudinal behavior of mucus plugs in asthma is needed to understand their role in mechanisms of airflow obstruction and to rationally design muco-active treatments. METHODS: CT lung scans from 57 patients with asthma were analyzed to quantify mucus plug size and airway location, and paired CT scans obtained 3 years apart were analyzed to determine plug behavior over time. Radiologist annotations of mucus plugs were incorporated in an image-processing pipeline to generate size and location information that was related to measures of airflow. RESULTS: The length distribution of 778 annotated mucus plugs was multimodal, and a 12 mm length defined short (“stubby”, ≤12 mm) and long (“stringy”, >12 mm) plug phenotypes. High mucus plug burden was disproportionately attributable to stringy mucus plugs. Mucus plugs localized predominantly to airway generations 6–9, and 47% of plugs in baseline scans persisted in the same airway for 3 years and fluctuated in length and volume. Mucus plugs in larger proximal generations had greater effects on spirometry measures than plugs in smaller distal generations, and a model of airflow that estimates the increased airway resistance attributable to plugs predicted a greater effect for proximal generations and more numerous mucus plugs. CONCLUSION: Persistent mucus plugs in proximal airway generations occur in asthma and demonstrate a stochastic process of formation and resolution over time. Proximal airway mucus plugs are consequential for airflow and are in locations amenable to treatment by inhaled muco-active drugs or bronchoscopy. TRIAL REGISTRATION: Clinicaltrials.gov; NCT01718197, NCT01606826, NCT01750411, NCT01761058, NCT01761630, NCT01716494, and NCT01760915. FUNDING: AstraZeneca, Boehringer-Ingelheim, Genentech, GlaxoSmithKline, Sanofi–Genzyme–Regeneron, and TEVA provided financial support for study activities at the Coordinating and Clinical Centers beyond the third year of patient follow-up. These companies had no role in study design or data analysis, and the only restriction on the funds was that they be used to support the SARP initiative.
- 26 July 2023
- Published by Elsevier in European Journal of Radiology
- Vol. 166, 111014
Image quality of photon counting and energy integrating chest CT – Prospective head-to-head comparison on same patients
- 26 July 2023
- Published by Elsevier in European Journal of Radiology
- Vol. 166, 111014
Image quality of photon counting and energy integrating chest CT – Prospective head-to-head comparison on same patients
- 1 July 2022
- Published by Springer Nature
- p. 245-266
Imaging of Thoracic Vascular Trauma
- 1 January 2021
- Published by Springer Nature
- p. 1-22
Imaging of Thoracic Vascular Trauma